or Try an Advanced Search...

    Technical Analysis for MOLN - Molecular Partners AG

    Grade Last Price % Change Price Change
    C 5.33 1.52% 0.08
    MOLN closed up 1.52 percent on Friday, November 15, 2024, on 89 percent of normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical MOLN trend table...
    Date Alert Name Type % Chg
    50 DMA Resistance Bearish 0.00%
    200 DMA Support Bullish 0.00%
    Doji - Bullish? Reversal 0.00%
    Outside Day Range Expansion 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Fell Below 50 DMA Bearish 1.52%
    NR7 Range Contraction 1.52%
    Narrow Range Bar Range Contraction 1.52%
    Stochastic Reached Oversold Weakness 1.52%
    Older End-of-Day Signals for MOLN ...

       Recent Intraday Alerts

    Alert Time
    200 DMA Support 1 day ago
    Rose Above Previous Day's High 1 day ago
    50 DMA Resistance 1 day ago
    2x Volume Pace 1 day ago
    1.5x Volume Pace 1 day ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    MOLN Chart by TradingView
    Basic chart:

    Profile

    Molecular Partners AG is a clinical-stage biotech company developing DARPin® therapeutics, a new class of custom-built protein drugs designed to address challenges current modalities cannot. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin® therapeutics in the areas of ophthalmology, oncology and infectious disease, and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Life Sciences Pharmaceutical Drugs Infectious Diseases Molecular Partners

    Is MOLN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 7 Molecular Partners Presents Preclinical Proof-of-Concept for CD3 Switch-DARPin T Cell Engager, Clinical Biomarker Analyses for MP0317 at SITC 2024
    Nov 5 Molecular Partners Announces Upcoming Poster Presentations at the 65th ASH Annual Meeting and Exposition
    Oct 31 Molecular Partners Q3 2024 Interim Management Statement: Multiple Updates Across Portfolio, Radio-DARPin candidate MP0712 preparing for clinical entry, MP0533 Phase 1 on-going
    Oct 25 Molecular Partners prices $20M offering
    Oct 25 Molecular Partners Announces Pricing of $20 Million Underwritten Offering
    Oct 23 Molecular Partners Expands Radio-DARPin Collaboration
    Oct 4 Molecular Partners Announces upcoming poster presentations at the 2024 SITC Annual Meeting
    Sep 27 Molecular Partners Announces Upcoming Top-Rated Oral Presentation on MP0712, a ²¹²Pb-labeled Radio-DARPin Therapeutic targeting DLL3 for Small Cell Lung Cancer co-developed with Orano Med, at EANM 2024
    Aug 26 Molecular Partners reports 1H results
    Aug 26 Molecular Partners Reports H1 2024 Corporate Highlights and Financials
    See more MOLN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 12.7
    52 Week Low 3.32
    Average Volume 20,869
    200-Day Moving Average 5.17
    50-Day Moving Average 5.37
    20-Day Moving Average 5.98
    10-Day Moving Average 5.79
    Average True Range 0.49
    RSI (14) 45.36
    ADX 21.83
    +DI 20.75
    -DI 23.77
    Chandelier Exit (Long, 3 ATRs) 6.12
    Chandelier Exit (Short, 3 ATRs) 6.35
    Upper Bollinger Bands 6.82
    Lower Bollinger Band 5.15
    Percent B (%b) 0.11
    BandWidth 28.04
    MACD Line 0.02
    MACD Signal Line 0.13
    MACD Histogram -0.1108
    Fundamentals Value
    Market Cap 175.11 Million
    Num Shares 32.9 Million
    EPS -2.09
    Price-to-Earnings (P/E) Ratio -2.55
    Price-to-Sales 17.37
    Price-to-Book 0.67
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.80
    Resistance 3 (R3) 5.77 5.60 5.72
    Resistance 2 (R2) 5.60 5.48 5.61 5.69
    Resistance 1 (R1) 5.46 5.41 5.49 5.49 5.67
    Pivot Point 5.29 5.29 5.30 5.30 5.29
    Support 1 (S1) 5.15 5.17 5.18 5.18 4.99
    Support 2 (S2) 4.98 5.10 4.99 4.97
    Support 3 (S3) 4.84 4.98 4.94
    Support 4 (S4) 4.87